Tonix Pharmaceuticals Holding Corp. (TNXP) Stock Analysis

Free AI-powered analysis and research for Tonix Pharmaceuticals Holding Corp. stock

Sector: Healthcare

Analyze Tonix Pharmaceuticals Holding Corp. (TNXP) Stock

Tonix Pharmaceuticals Holding Corp. (TNXP) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into TNXP stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for Tonix Pharmaceuticals Holding Corp. stock.

Analyze TNXP Now →

📰 Latest Update

TNXP: $11.0 Million in Tonmya® Net Revenue in 2Q26

Wed, September 2, 2026 at 1:38 PM UTC 2 min read

TNXP reported $11.0 million in net revenue from its Tonmya® product for the second quarter of 2026, indicating a strong performance in its commercial launch. This revenue figure is significant for investors as it demonstrates the product's market acceptance and potential for future growth, reinforcing the company's financial stability and strategic positioning in the pharmaceutical sector. Investors may view this positive trend as a catalyst for further stock appreciation.

Read full article →